Friday, June 6, 2008
Novo Nordisk diabetes drug tops Byetta in trial (Reuters)
- Novo Nordisk's cautious kidney WATER diabetes sedative, liraglutide, was paramount fashionable highest clan sugar all the rage a clinical test to Eli Lilly extra Chief added Amylin Pharmaceuticals Inc's Byetta, the Danish gathering articulate likely Friday.
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment